These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17334528)

  • 1. Antagonic effect of the inhibition of inducible nitric oxide on the mortality of mice acutely infected with Escherichia coli and Bacteroides fragilis.
    Astolfi RS; Khouri DG; Brandizzi LI; Avila-Campos MJ; Andrade HF
    Braz J Med Biol Res; 2007 Mar; 40(3):317-22. PubMed ID: 17334528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of moxifloxacin versus imipenem/cilastatin treatment on the mortality of mice infected intravenously with different strains of Bacteroides fragilis and Escherichia coli.
    Schaumann R; Blatz R; Beer J; Ackermann G; Rodloff AC
    J Antimicrob Chemother; 2004 Feb; 53(2):318-24. PubMed ID: 14729746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of metronidazole on Escherichia coli in the presence of Bacteroides fragilis: an investigation in mice.
    Reznikov M; McDonald PJ
    Chemotherapy; 1983; 29(3):225-9. PubMed ID: 6347547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of cefminox compared with amoxicillin/clavulanic acid as a single dose for the prevention of intra-abdominal sepsis in mice intraperitoneally infected with different strains of Escherichia coli and one strain of Bacteroides fragilis.
    Huelves L; Gracia M; Del Prado G; Rodríguez-Cerrato V; Martínez-Marín C; Ponte C; Soriano F; Coronel P; Gimeno M; Blanco J
    Int J Antimicrob Agents; 2006 Aug; 28(2):151-3. PubMed ID: 16815688
    [No Abstract]   [Full Text] [Related]  

  • 5. Detrimental effects of a nitric oxide synthase inhibitor (N-omega-nitro-L-arginine-methyl-ester) in a murine sepsis model.
    Fukatsu K; Saito H; Fukushima R; Inoue T; Lin MT; Inaba T; Muto T
    Arch Surg; 1995 Apr; 130(4):410-4. PubMed ID: 7710342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of nitric oxide synthase inhibition in lipopolysaccharide-induced sepsis in mice.
    Tunçtan B; Uludag O; Altug S; Abacioglu N
    Pharmacol Res; 1998 Nov; 38(5):405-11. PubMed ID: 9806822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo efficacy of trovafloxacin against Bacteroides fragilis in mixed infection with either Escherichia coli or a vancomycin-resistant strain of Enterococcus faecium in an established-abscess murine model.
    Stearne LE; Gyssens IC; Goessens WH; Mouton JW; Oyen WJ; van der Meer JW; Verbrugh HA
    Antimicrob Agents Chemother; 2001 May; 45(5):1394-401. PubMed ID: 11302801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exogenous nitric oxide enhances the prophylactic effect of aminoguanidine, a preferred iNOS inhibitor, on bleomycin-induced fibrosis in the lung: Implications for the direct roles of the NO molecule in vivo.
    Chen C; Yun XJ; Liu LZ; Guo H; Liu LF; Chen XL
    Nitric Oxide; 2017 Nov; 70():31-41. PubMed ID: 28757441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of inducible nitric oxide controls pathogen load and brain damage by enhancing phagocytosis of Escherichia coli K1 in neonatal meningitis.
    Mittal R; Gonzalez-Gomez I; Goth KA; Prasadarao NV
    Am J Pathol; 2010 Mar; 176(3):1292-305. PubMed ID: 20093483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of selective nitric oxide synthase inhibitor on nitric oxide and PGE2 levels in refractory hemorrhagic-shocked rats.
    Md S; Moochhala SM; Siew Yang KL; Lu J; Anuar F; Mok P; Ng KC
    J Surg Res; 2005 Feb; 123(2):206-14. PubMed ID: 15680380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of nitric oxide production by aminoguanidine influences the number of Trichinella spiralis parasites in infected "low responders" (C57BL/6) and "high responders" (BALB/c) mice.
    Kołodziej-Sobocińska M; Dziemian E; Machnicka-Rowińska B
    Parasitol Res; 2006 Jul; 99(2):194-6. PubMed ID: 16541259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective inhibition of nitric oxide production by aminoguanidine does not reverse hypotension in endotoxaemic rats.
    Metcalf K; Jungersten L; Lisander B
    Acta Anaesthesiol Scand; 2002 Jan; 46(1):17-23. PubMed ID: 11903067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenicity of capsulate and non-capsulate members of Bacteroides fragilis and B. melaninogenicus groups in mixed infection with Escherichia coli and Streptococcus pyogenes.
    Brook I
    J Med Microbiol; 1988 Nov; 27(3):191-8. PubMed ID: 2903934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exogenous carbon monoxide suppresses Escherichia coli vitality and improves survival in an Escherichia coli-induced murine sepsis model.
    Shen WC; Wang X; Qin WT; Qiu XF; Sun BW
    Acta Pharmacol Sin; 2014 Dec; 35(12):1566-76. PubMed ID: 25399652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ascorbate protects against impaired arteriolar constriction in sepsis by inhibiting inducible nitric oxide synthase expression.
    Wu F; Wilson JX; Tyml K
    Free Radic Biol Med; 2004 Oct; 37(8):1282-9. PubMed ID: 15451067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrin in peritonitis. IV. Synergistic intraperitoneal infection caused by Escherichia coli and Bacteroides fragilis within fibrin clots.
    Dunn DL; Rotstein OD; Simmons RL
    Arch Surg; 1984 Feb; 119(2):139-44. PubMed ID: 6365029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-tumor necrosis factor antibody reduces mortality in the presence of antibiotic-induced tumor necrosis factor release.
    Sawyer RG; Adams RB; May AK; Rosenlof LK; Pruett TL
    Arch Surg; 1993 Jan; 128(1):73-7; discussion 77-8. PubMed ID: 8418784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmented inducible nitric oxide synthase expression and increased NO production reduce sepsis-induced lung injury and mortality in myeloperoxidase-null mice.
    Brovkovych V; Gao XP; Ong E; Brovkovych S; Brennan ML; Su X; Hazen SL; Malik AB; Skidgel RA
    Am J Physiol Lung Cell Mol Physiol; 2008 Jul; 295(1):L96-103. PubMed ID: 18424617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro susceptibility and in vivo efficacy of antimicrobials in the treatment of Bacteroides fragilis-Escherichia coli infection in mice.
    Brook I
    J Infect Dis; 1989 Oct; 160(4):651-6. PubMed ID: 2677161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacteroides fragilis interferes with iNOS activity and leads to pore formation in macrophage surface.
    Vieira JM; Vallim DC; Ferreira EO; Seabra SH; Vommaro RC; Avelar KE; De Souza W; Ferreira MC; Domingues RM
    Biochem Biophys Res Commun; 2005 Jan; 326(3):607-13. PubMed ID: 15596142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.